179 related articles for article (PubMed ID: 22359160)
1. The genetic basis of primary aldosteronism.
Funder JW
Curr Hypertens Rep; 2012 Apr; 14(2):120-4. PubMed ID: 22359160
[TBL] [Abstract][Full Text] [Related]
2. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.
Mulatero P; Tauber P; Zennaro MC; Monticone S; Lang K; Beuschlein F; Fischer E; Tizzani D; Pallauf A; Viola A; Amar L; Williams TA; Strom TM; Graf E; Bandulik S; Penton D; Plouin PF; Warth R; Allolio B; Jeunemaitre X; Veglio F; Reincke M
Hypertension; 2012 Feb; 59(2):235-40. PubMed ID: 22203740
[TBL] [Abstract][Full Text] [Related]
3. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
[TBL] [Abstract][Full Text] [Related]
4. Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
Murthy M; Xu S; Massimo G; Wolley M; Gordon RD; Stowasser M; O'Shaughnessy KM
Hypertension; 2014 Apr; 63(4):783-9. PubMed ID: 24420545
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Sertedaki A; Markou A; Vlachakis D; Kossida S; Campanac E; Hoffman DA; Sierra ML; Xekouki P; Stratakis CA; Kaltsas G; Piaditis GP; Chrousos GP; Charmandari E
Clin Endocrinol (Oxf); 2016 Dec; 85(6):845-851. PubMed ID: 27293068
[TBL] [Abstract][Full Text] [Related]
6. Primary aldosteronism and potassium channel mutations.
Stowasser M
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):170-9. PubMed ID: 23426162
[TBL] [Abstract][Full Text] [Related]
7. Genetics of primary aldosteronism.
Funder JW
Front Horm Res; 2014; 43():70-8. PubMed ID: 24943299
[TBL] [Abstract][Full Text] [Related]
8. Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.
Aristizabal Prada ET; Castellano I; Sušnik E; Yang Y; Meyer LS; Tetti M; Beuschlein F; Reincke M; Williams TA
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642543
[TBL] [Abstract][Full Text] [Related]
9. [Primary aldosteronism: new insights into familial forms].
van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J
Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144
[TBL] [Abstract][Full Text] [Related]
10. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
[TBL] [Abstract][Full Text] [Related]
11. Familial hyperaldosteronism type III.
Monticone S; Tetti M; Burrello J; Buffolo F; De Giovanni R; Veglio F; Williams TA; Mulatero P
J Hum Hypertens; 2017 Dec; 31(12):776-781. PubMed ID: 28447626
[TBL] [Abstract][Full Text] [Related]
12. Role of KCNJ5 in familial and sporadic primary aldosteronism.
Mulatero P; Monticone S; Rainey WE; Veglio F; Williams TA
Nat Rev Endocrinol; 2013 Feb; 9(2):104-12. PubMed ID: 23229280
[TBL] [Abstract][Full Text] [Related]
13. Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia.
Maria AG; Suzuki M; Berthon A; Kamilaris C; Demidowich A; Lack J; Zilbermint M; Hannah-Shmouni F; Faucz FR; Stratakis CA
Am J Hypertens; 2020 Feb; 33(2):124-130. PubMed ID: 31637427
[TBL] [Abstract][Full Text] [Related]
14. Somatic and inherited mutations in primary aldosteronism.
Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Mol Endocrinol; 2017 Jul; 59(1):R47-R63. PubMed ID: 28400483
[TBL] [Abstract][Full Text] [Related]
15. Familial hyperaldosteronism type III a novel case and review of literature.
Pons Fernández N; Moreno F; Morata J; Moriano A; León S; De Mingo C; Zuñiga Á; Calvo F
Rev Endocr Metab Disord; 2019 Mar; 20(1):27-36. PubMed ID: 30569443
[TBL] [Abstract][Full Text] [Related]
16. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
[TBL] [Abstract][Full Text] [Related]
17. GENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism.
Monticone S; Buffolo F; Tetti M; Veglio F; Pasini B; Mulatero P
Eur J Endocrinol; 2018 Mar; 178(3):R101-R111. PubMed ID: 29348113
[TBL] [Abstract][Full Text] [Related]
18. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
Scholl UI; Lifton RP
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
[TBL] [Abstract][Full Text] [Related]
19. Genetic disorders in primary aldosteronism-familial and somatic.
Funder JW
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):154-157. PubMed ID: 27013018
[TBL] [Abstract][Full Text] [Related]
20. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
